Alan Robert Saltiel

USPTO Granted Patents = 23 (Patent Applications = 3)

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 3.1

ph-index = 11

Forward Citations = 482(Granted Patents)

Location History:

Irvington, NY (US) (1989)
New York, NY (US) (1990)
Ann Arbor, MI (US) (1996 - 2020)

Company Filing History:

15 out of 2,538

Warner-lambert Company

patents

6 out of 3,381

University of Michigan

patents

2 out of 712

The Rockefeller University

patents

Years Active: 1989-2020

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10590142 - Deuterated amlexanox (2020-03-17),

2. 10245255 - Compositions and methods for the treatment of obesity and related disorders (2019-04-02),

3. 10214536 - Amlexanox analogs (2019-02-26),

4. 9944652 - Deuterated amlexanox (2018-04-17),

5. 9365581 - Deuterated amlexanox (2016-06-14),

6. 8946424 - Deuterated amlexanox (2015-02-03),

7. 7169816 - 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors (2007-01-30),

8. 7019033 - 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives (2006-03-28),

9. 6821963 - 4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors (2004-11-23),

10. 6696440 - Treatment of asthma with MEK inhibitors (2004-02-24),

11. 6492363 - 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives (2002-12-10),

12. 6310060 - 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors (2001-10-30),

13. 6252057 - Protein targeting to glycogen (2001-06-26),

14. 6251943 - Method of treating or preventing septic shock by administering a MEK inhibitor (2001-06-26),

15. 5922697 - Compounds, compositions and methods for inhibiting the binding of (1999-07-13),

Title: Alan Robert Saltiel - Innovator from Ann Arbor

Introduction: Alan Robert Saltiel is a renowned inventor based in Ann Arbor, Michigan. His groundbreaking work in the field of biotechnology and genetics has earned him international recognition.

Latest Patents: Alan Robert Saltiel holds several patents related to novel gene editing techniques and therapeutic interventions for metabolic disorders. His most recent patent focuses on a revolutionary method for targeting specific genes associated with diabetes.

Career Highlights: With a distinguished career spanning over three decades, Saltiel has held key research positions at prestigious institutions such as the University of Michigan and the Howard Hughes Medical Institute. He has published numerous research papers that have significantly advanced our understanding of metabolic diseases.

Collaborations: Saltiel has collaborated with leading pharmaceutical companies and research institutions worldwide to develop innovative treatments for diabetes, obesity, and other metabolic conditions. His collaborative efforts have resulted in the development of cutting-edge therapies that are currently in clinical trials.

Conclusion: Alan Robert Saltiel's relentless pursuit of scientific excellence and his passion for improving human health have cemented his reputation as a pioneering inventor in the field of biotechnology. His innovative contributions continue to inspire the next generation of researchers and innovators.

This text is generated by artificial intelligence and may not be accurate.